Literature DB >> 24276780

Mounting evidence for prediagnostic use of statins in reducing risk of lethal prostate cancer.

Lorelei A Mucci1, Meir J Stampfer.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 24276780     DOI： 10.1200/JCO.2013.53.2770

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  17 in total

1.  Associations among statins, preventive care, and prostate cancer mortality.

Authors:  Abhishek Kumar; Paul Riviere; Elaine Luterstein; Vinit Nalawade; Lucas Vitzthum; Reith R Sarkar; Alex K Bryant; John P Einck; Arno J Mundt; James D Murphy; Brent S Rose
Journal:  Prostate Cancer Prostatic Dis       Date:  2020-02-06       Impact factor: 5.554

Review 2.  Cardio-oncology Related to Heart Failure: Common Risk Factors Between Cancer and Cardiovascular Disease.

Authors:  Anne Blaes; Anna Prizment; Ryan J Koene; Suma Konety
Journal:  Heart Fail Clin       Date:  2017-04       Impact factor: 3.179

3.  CYP27A1 Loss Dysregulates Cholesterol Homeostasis in Prostate Cancer.

Authors:  Mahmoud A Alfaqih; Erik R Nelson; Wen Liu; Rachid Safi; Jeffery S Jasper; Everardo Macias; Joseph Geradts; J Will Thompson; Laura G Dubois; Michael R Freeman; Ching-Yi Chang; Jen-Tsan Chi; Donald P McDonnell; Stephen J Freedland
Journal:  Cancer Res       Date:  2017-01-27       Impact factor: 12.701

Review 4.  The current evidence on statin use and prostate cancer prevention: are we there yet?

Authors:  Mahmoud A Alfaqih; Emma H Allott; Robert J Hamilton; Michael R Freeman; Stephen J Freedland
Journal:  Nat Rev Urol       Date:  2016-10-25       Impact factor: 14.432

5.  Evidence for Feedback Regulation Following Cholesterol Lowering Therapy in a Prostate Cancer Xenograft Model.

Authors:  Elizabeth M Masko; Mahmoud A Alfaqih; Keith R Solomon; William T Barry; Christopher B Newgard; Michael J Muehlbauer; Nikolaos A Valilis; Tameika E Phillips; Susan H Poulton; Alexis R Freedland; Stephanie Sun; Shweta K Dambal; Sergio E Sanders; Everardo Macias; Michael R Freeman; Mark W Dewhirst; Salvatore V Pizzo; Stephen J Freedland
Journal:  Prostate       Date:  2016-11-30       Impact factor: 4.104

6.  Longer-term Lipid-lowering Drug Use and Risk of Incident and Fatal Prostate Cancer in Black and White Men in the ARIC Study.

Authors:  Alison M Mondul; Corinne E Joshu; John R Barber; Anna E Prizment; Nrupen A Bhavsar; Elizabeth Selvin; Aaron R Folsom; Elizabeth A Platz
Journal:  Cancer Prev Res (Phila)       Date:  2018-10-16

7.  Statin Use at the Time of Initiation of Androgen Deprivation Therapy and Time to Progression in Patients With Hormone-Sensitive Prostate Cancer.

Authors:  Lauren C Harshman; Xiaodong Wang; Mari Nakabayashi; Wanling Xie; Loana Valenca; Lillian Werner; Yongjiang Yu; Aaron M Kantoff; Christopher J Sweeney; Lorelei A Mucci; Mark Pomerantz; Gwo-Shu Mary Lee; Philip W Kantoff
Journal:  JAMA Oncol       Date:  2015-07       Impact factor: 31.777

8.  Metformin effects on biochemical recurrence and metabolic signaling in the prostate.

Authors:  Brian Winters; Stephen Plymate; Steven B Zeliadt; Sarah Holt; Xiaotun Zhang; Elaine Hu; Daniel W Lin; Colm Morrissey; Bryan Wooldridge; John L Gore; Michael P Porter; Jonathan L Wright
Journal:  Prostate       Date:  2015-07-22       Impact factor: 4.104

9.  Statin use and risk of prostate cancer: Results from the Southern Community Cohort Study.

Authors:  Elizabeth D Kantor; Loren Lipworth; Jay H Fowke; Edward L Giovannucci; Lorelei A Mucci; Lisa B Signorello
Journal:  Prostate       Date:  2015-05-27       Impact factor: 4.104

Review 10.  Shared Risk Factors in Cardiovascular Disease and Cancer.

Authors:  Ryan J Koene; Anna E Prizment; Anne Blaes; Suma H Konety
Journal:  Circulation       Date:  2016-03-15       Impact factor: 29.690
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.